Daily non-political popular news in brief.

Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer

In an editorial in today's New England Journal of Medicine, a colon cancer researcher at the Ireland Cancer Center of University Hospitals Case Medical Center has laid out the roadmap for how medical science should employ aspirin and new aspirin-like drugs for use in preventing colon cancer in certain high-risk individuals.

Read more »

Keywords: ireland, cancer, center, researcher, lays, benefits, aspirin, prevent, colon, lay, benefit

« Previous | Next »

Similar news on "Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer":

1. Ireland Cancer Center researcher finds standard treatment for breast cancer not followed
   12-21-2007 · EurekAlert!
   Research out of the Ireland Cancer Center of University Hospitals Case Medical Center, in collaboration with six integrated health plans that are part of the Cancer Research Network, found that the majority of older women with early stage breast cancer fail to adhere to the standard of treatment -- five years of daily oral use of the chemo-prevention drug Tamoxifen.
   Similar news · Read more »
   
2. Genetic variation impacts aspirin's effectiveness in preventing colon cancer, Dartmouth study finds
   10-24-2006 · EurekAlert!
   Dartmouth researchers are among a team of doctors that have learned more about how people may or may not benefit from taking aspirin in the effort to curb colon cancer.
   Similar news · Read more »
   
3. Smokers might benefit from earlier colon cancer screening
   02-13-2008 · EurekAlert!
   New evidence suggests screening for colorectal cancer, which is now recommended to begin at age 50 for most people, should start five to 10 years earlier for individuals with a significant lifetime exposure to tobacco smoke, a University of Rochester Medical Center study said.
   Similar news · Read more »
   
4. Analysis of breast and colon cancer genes finds many areas of differences between tumors
   10-11-2007 · EurekAlert!
   Researchers from University Hospitals Ireland Cancer Center and Case Western Reserve University School of Medicine are part of a new national study that has analyzed more than 18,000 genes, including 5,000 previously unmapped genes, from breast and colorectal tumors. The study shows a great number of genetic differences between breast and colon cancer tumors, leading the researchers to conclude that new drugs must be developed that can hit these newly identified genetic targets in a manner specific to each different individual's tumor.
   Similar news · Read more »
   
5. Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend
   01-21-2008 · EurekAlert!
   Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer.
   Similar news · Read more »
   
6. Pros, cons of drug proven to prevent prostate cancer should be considered, UT Southwestern researchers recommend
   01-21-2008 · UT Southwestern Medical Center
   Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer.
   Similar news · Read more »
   
7. What cures your aches might prevent cancer
   11-29-2006 · EurekAlert!
   Mayo Clinic Cancer Center has begun three clinical studies looking at the use of nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent cancer -- colon, esophageal or lung.
   Similar news · Read more »
   
8. Can a Mediterranean diet help prevent colon cancer?
   06-13-2007 · EurekAlert!
   Researchers at the University of Michigan Comprehensive Cancer Center are beginning a study to look at whether diet can impact a person's risk of developing colon cancer. Specifically, the researchers will compare a Mediterranean diet -- high in olive oil, nuts and fish -- with a standard healthy eating plan.
   Similar news · Read more »
   
9. Benefit of cancer prevention surgery differs between women with BRCA1 and BRCA2 mutations
   02-11-2008 · EurekAlert!
   The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations. A new multicenter study led by researchers at Memorial Sloan-Kettering Cancer Center is the first prospective examination of the impact of this procedure in which BRCA2 mutation carriers were analyzed separately from BRCA1 mutation carriers.
   Similar news · Read more »
   
10. Poorer women more likely to get reduced chemotherapy dose, study finds
    01-18-2007 · EurekAlert!
    Breast cancer patients who have a lower household income and less education may be more likely to receive reduced doses of chemotherapy, according to a new study from a University of Michigan Comprehensive Cancer Center researcher.
    Similar news · Read more »